|
2 Companies |
|
1 Product |
|
1 Product |
|
2 Mechanisms of Action |
|
0 Trials |
|
4 News |
|
- Enrollment change: Clinical Assessment of Spinal Muscular Atrophy Type II and III (SMA Europe) (clinicaltrials.gov) - Mar 3, 2014
P=N/A, N=4, Completed, Sponsor: Institut de Myologie, France
N=16 --> 4
- Trial completion: Clinical Assessment of Spinal Muscular Atrophy Type II and III (SMA Europe) (clinicaltrials.gov) - Mar 3, 2014
P=N/A, N=4, Completed, Sponsor: Institut de Myologie, France
N=16 --> 4 Recruiting --> Completed
- |||| olesoxime (TRO19622) / Roche
Trial completion: Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients. (clinicaltrials.gov) - Oct 17, 2013
P2, N=165, Completed, Sponsor: Trophos
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Pilot Study of Growth Hormon to Treat SMA Typ II and III (clinicaltrials.gov) - Jan 31, 2013
P2, N=20, Completed, Sponsor: University Hospital Freiburg
Active, not recruiting --> Completed Active, not recruiting --> Completed